Search Results - Maarten O. van Aken
- Showing 1 - 15 results of 15
-
1
-
2
-
3
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours by Martijn van Essen, Eric P. Krenning, Boen L.R. Kam, Wouter W. de Herder, Maarten O. van Aken, Dik J. Kwekkeboom
Published 2008Artigo -
4
Mortality in Patients Treated for Cushing’s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma by Olaf M. Dekkers, Nienke R. Biermasz, Alberto M. Pereira, Ferdinand Roelfsema, Maarten O. van Aken, J. H. C. Voormolen, Johannes A. Romijn
Published 2007Artigo -
5
-
6
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate by Bart de Keizer, Maarten O. van Aken, Richard A. Feelders, Wouter W. de Herder, Boen L.R. Kam, Martijn van Essen, Eric P. Krenning, Dik J. Kwekkeboom
Published 2008Artigo -
7
Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant by Sebastian Neggers, Maarten O. van Aken, Wouter W. de Herder, Richard A. Feelders, J. A. M. J. L. Janssen, Xavier Badı́a, Susan M. Webb, A. J. van der Lely
Published 2008Artigo -
8
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease by Maarten O. van Aken, Alberto M. Pereira, Nienke R. Biermasz, Sandra van Thiel, Hendrieke C. Hoftijzer, Johannes W. A. Smit, Ferdinand Roelfsema, Steven W. J. Lamberts, Johannes A. Romijn
Published 2005Artigo -
9
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire by Susan M. Webb, Xavier Badı́a, María José Barahona, Annamaria Colao, Christian J. Strasburger, Antoine Tabarin, Maarten O. van Aken, Rosario Pivonello, Günter K. Stalla, Steven W. J. Lamberts, J. E. Glusman
Published 2008Artigo -
10
Treatment With the Radiolabeled Somatostatin Analog [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]Octreotate: Toxicity, Efficacy, and Survival by Dik J. Kwekkeboom, Wouter W. de Herder, Boen L.R. Kam, Casper H.J. van Eijck, Martijn van Essen, P.P.M. Kooij, Richard A. Feelders, Maarten O. van Aken, Eric P. Krenning
Published 2008Artigo -
11
Salivary Cortisol Is Related to Atherosclerosis of Carotid Arteries by Marieke J. H. J. Dekker, Jan W. Koper, Maarten O. van Aken, H. A. P. Pols, Albert Hofman, Frank H. de Jong, Clemens Kirschbaum, J. C. M. Witteman, Steven W. J. Lamberts, Henning Tiemeier
Published 2008Artigo -
12
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5 by Leo J. Hofland, Joost van der Hoek, Richard A. Feelders, Maarten O. van Aken, Peter M. van Koetsveld, Marlijn Waaijers, Diana Sprij-Mooij, Christian Bruns, Gisbert Weckbecker, Wouter W. de Herder, Albert Beckers, Steven W. J. Lamberts
Published 2005Artigo -
13
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas by Christiaan de Bruin, Alberto M. Pereira, Richard A. Feelders, Johannes A. Romijn, Ferdinand Roelfsema, Diane M. Sprij-Mooij, Maarten O. van Aken, Aart‐Jan van der Lelij, Wouter W. de Herder, Steven W. J. Lamberts, Leo J. Hofland
Published 2009Artigo -
14
Biochemical Predictors of Outcome of Pituitary Surgery for Cushing’s Disease by R A Alwani, Wouter W. de Herder, Maarten O. van Aken, J.H. van den Berge, E. J. Delwel, A.H.G. Dallenga, Frank H. de Jong, S.W.J. Lamberts, A. J. van der Lely, Richard A. Feelders
Published 2009Artigo -
15
Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype by Kim van der Weerd, Willem A. Dik, Benjamin Schrijver, Dave H. Schweitzer, Anton W. Langerak, Hemmo A. Drexhage, Rosalie M. Kiewiet, Maarten O. van Aken, Astrid van Huisstede, Jacques J. M. van Dongen, Aart‐Jan van der Lelij, Frank J. T. Staal, P. Martin van Hagen
Published 2012Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Endocrinology
Somatostatin
Gastroenterology
Biology
Cushing's disease
Disease
Hormone
Adenoma
Octreotide
Pituitary adenoma
Radionuclide therapy
Neuroendocrine tumors
Nursing
Pathology
Quality of life (healthcare)
Somatostatin receptor
Acromegaly
Adverse effect
Alternative medicine
Cancer
Cohort
Confidence interval
Corticotropic cell
Growth hormone
Hydrocortisone
Nuclear medicine
Pediatrics
Pegvisomant